In molecular radiotherapy (MRT) treatment of the thyroid, existing single photon emission computed tomography (SPECT) ...
September 5, 2019 — An ahead-of-print article published in the December issue of the American Journal of Roentgenology ...
Heidelberg University Hospital, Germany, has treated its first patient using Monte Carlo photon dose planning in RayStation. The decision to go clinical was made after a thorough validation of the functionality. The first patient, who has cervical cancer involving the lymph nodes, was recently treated.
eHealth Saskatchewan plays a vital role in providing IT services to patients, health care providers, and partners such ...
The global rise in chronic disease has significantly increased demand for diagnostic imaging procedures, and in turn ...
Extracapsular extension (ECE) is a major clinical indicator for brachytherapy or external beam treatment of prostate ...
Iridium Cancer Network consists of all seven hospitals in the Antwerp region, closely collaborating regarding radiation ...
While most women understand the importance of health screenings, an estimated 72 million have missed or postponed a ...
Burnout has become a popular buzzword in today’s business world, meant to describe prolonged periods of stress in the ...
Doctors and technologists are exposed to on-the-job radiation often on a daily basis. It is critical to be aware of how ...
In healthcare, critical systems are being used to deliver vital information and services 24x7x365. Clinicians demand ...
Fujifilm’s APERTO Lucent is a 0.4T mid-field, open MRI system addressing today’s capability and image quality needs ...
OSF HealthCare in Peoria, Ill., recently added a new Carestream DRX-Evolution Plus System to its portfolio of Carestream imaging solutions across the integrated health system’s diverse operations. The imaging portfolio include Carestream DRX-Revolution mobile X-ray systems and Carestream DRX-Ascend systems, along with Carestream DRX-Plus detectors.
LAP LLC announced its Apollo MR3T positioning laser for radiation therapy has received U.S. Food and Drug Administration (FDA) 510(k) approval. The magnetic resonance (MR)-compatible room laser is currently the only product of its class approved the FDA, according to the company.
Global Diagnostics Australia (GDA), a subsidiary of the Integral Diagnostics Group (IDX), has adopted artificial intelligence (AI) applications into its radiology workflow, and is one of the first diagnostic imaging companies in Australia to do so. GDA has partnered with AI company Aidoc to incorporate their algorithms into GDA's care management pathway. These AI applications will expedite patient diagnosis and treatment for several head, neck and chest conditions.
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
Radiology’s history dates back to 1895 when Wilhelm Roentgen discovered X-rays. The very first image taken was of his ...
Help may be on the way for people who might lose contact with reality through a psychotic disorder, such as schizophrenia.
Modus QA is proud to offer the world's first MR-safe Motion QA phantom for simulation, planning and delivery ...
Despite a broad campaign among physician groups to reduce the amount of medical imaging, use rates of various scans have continued to increase in both the U.S. and Ontario, Canada, according to a new study. A recent reacceleration in the growth of imaging concerns researchers because it is widely believed to be overused. The study of more than 135 million imaging exams was conducted by researchers at UC Davis, UC San Francisco and Kaiser Permanente.
New Zealand-based Adept Medical announced the launch of the Antegrade IR Platform. Clinically driven, it is placed to provide an ideal work surface for antegrade femoral approach during interventional radiology vascular procedures. The device sits within the company’s existing range of access and patient positioning devices designed for interventional radiology, cardiology and vascular procedures.
Researchers have validated a first-of-its-kind machine learning–based model to evaluate immunohistochemical (IHC) characteristics in patients with suspected thyroid nodules, according to an ahead-of-print article published in the December issue of the American Journal of Roentgenology (AJR). The research team achieved “excellent performance” for individualized noninvasive prediction of the presence of cytokeratin 19, galectin 3 and thyroperoxidase based upon computed tomography (CT) images.
Researchers in South Korea have found that patients with family and personal history of allergic reactions to contrast media are at risk for future reactions, according to a large study published in the journal Radiology.1 Allergic reactions to commonly used computed tomography (CT) contrast media may be prevented by premedicating patients with antihistamines and using a different type of contrast agent.
Philips will showcase its latest cardiac care innovations at the European Society of Cardiology (ESC) Congress 2019, Aug. 31–Sept. 4 in Paris, France. At the congress, Philips is showcasing Release 5.0 of its Epiq CVx cardiology platform for the first time in Europe. The platform includes automated applications for 2-D assessment of the heart, as well as robust 3-D right ventricle volume and ejection fraction measurements, making accurate exams faster and easier to conduct. Philips also announced that it is collaborating with digital health company LindaCare to combine the latter’s OnePulse cloud-based solution for the remote monitoring of patients with cardiac implantable electronic devices (CIEDs) with the Philips IntelliSpace Cardiovascular informatics platform.